Banking

Biotech Zai Lab Stock Sees Relative Strength Rating Jump To 83

Zai Lab Limited (ZLAB) saw a positive improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 80 to 83.

When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

This proprietary rating tracks market leadership by showing how a stock’s price action over the last 52 weeks measures up against that of the other stocks in our database.

Decades of market research shows that the stocks that go on to make the biggest gains tend to have an RS Rating north of 80 in the early stages of their moves.


Looking For The Best Stocks To Buy And Watch? Start Here


Is Zai Lab Stock A Buy?

Zai Lab Limited stock is building a cup with handle with a 177.99 buy point. See if the stock can clear the breakout price in volume at least 40% higher than normal. It’s a later-stage pattern, and investors should be aware that those are less likely to work. Read “Looking For The Next Big Stock Market Winners? Start With These 3 Steps” for more tips.

The Chinese biotech firm posted -300% earnings growth last quarter. Sales rose 145%.

Zai Lab Limited stock holds the No. 78 rank among its peers in the Medical-Biomed/Biotech industry group. Alexion Pharmaceuticals (ALXN) and Maravai Lifesciences (MRVI) are also among the group’s highest-rated stocks. For more industry news, check out “Biotech And Pharmaceutical Industry And Stock News.”

YOU MIGHT ALSO LIKE:

MarketSmith’s Tools Can Help The Individual Investor

IBD Live: A New Tool For Daily Stock Market Analysis

Profit From Short-Term Trends With SwingTrader

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

 

Most Related Links :
Business News Governmental News Finance News

Source link

Back to top button